Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry

Pseudophakic Eyes Implanted With Different Presbyopia-correcting IOL Designs: 3-D Anterior Segment OCT Biometry and Pyramid Wavefront Sensing- Based Retinal Image Quality

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To correlate ocular morphology from anterior segment OCT and pyramid wavefront sensing in order to comprehensively analyze pseudophakic in vivo image quality of presbyopia-correcting IOLs in cataract patients.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Men and women aged above 21 years with prior uncomplicated cataract/IOL exchange surgery 2. Willing to sign willing to sign a consent form before measurements 3. Corrected distance visual acuity (CDVA) of 0.1 logMAR or better 4. Absence of corneal scars/dry eye disease that could falsify the light transmission of the study eye 5. Total absence of posterior capsule opacification or patients who already have undergone Nd:YAG capsulotomy 6. Absence of ocular comorbidity (Macular degeneration, glaucoma, amblyopia) Who Should NOT Join This Trial: 1. Prior corneal refractive or ocular surgery 2. Posterior capsule opacification. 3. Keratometry between \<42.5 and \>45 D, 4. Corneal spherical aberration \> 0.4 microns 5) Angle kappa \> 0.4 mm 6\) Zonular weakness 7) Pseudoexfoliation syndrome 8) Eccentric fixation or insufficient ability to fixate (tremor, nystagmus) 9) Pregnancy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Men and women aged above 21 years with prior uncomplicated cataract/IOL exchange surgery 2. Willing to sign informed consent before measurements 3. Corrected distance visual acuity (CDVA) of 0.1 logMAR or better 4. Absence of corneal scars/dry eye disease that could falsify the light transmission of the study eye 5. Total absence of posterior capsule opacification or patients who already have undergone Nd:YAG capsulotomy 6. Absence of ocular comorbidity (Macular degeneration, glaucoma, amblyopia) Exclusion Criteria: 1. Prior corneal refractive or ocular surgery 2. Posterior capsule opacification. 3. Keratometry between \<42.5 and \>45 D, 4. Corneal spherical aberration \> 0.4 microns 5) Angle kappa \> 0.4 mm 6\) Zonular weakness 7) Pseudoexfoliation syndrome 8) Eccentric fixation or insufficient ability to fixate (tremor, nystagmus) 9) Pregnancy

Treatments Being Tested

DEVICE

Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

The Osiris-T aberrometer is a CE-certified device that operates via a high-resolution four-faced pyramid wavefront sensor (PWS) to analyze light intensity among four images (sub-apertures) of the patients ́entrance pupil akin to a Foucault knife-edge test. Thereby measurements of the wavefront and refractive error can be quantified non-invasively. The sampling density of the wavefront error is 45,000 points at maximum pupil. The device uses a near-infrared extended light-emitting diode source emitting at 850 nm. Its is additionally intertwined with a corneal topography system to also characterize the corneal aberrations and compute via direct subtraction the internal ocular optics.

Locations (2)

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria